Among women <35 years of age diagnosed with breast cancer, the frequency of germline TP53 mutations ranges from 1–7% and can reach up to 30% in those diagnosed before the age of 30 [118,124,125,126,127,128,129]. This evidence concerns the gene TP53 and breast cancer.